Anti-Tumor Necrosis Factor NewsLatest News On Anti-Tumor Necrosis Factor Primary Sclerosing Cholangitis Affects Outcomes in Paediatric IBD8/23/2025 3:48 AM Interclass Biologic Switching Improves Effectiveness in Psoriasis8/7/2025 3:18 AM Mild and Moderate Infections Common in IBD, Rates Vary by Choice of Treatment7/16/2025 11:57 AM Rheumatoid Nodules: Rare, Recurrent, and Still a Challenge7/3/2025 2:18 AM Disease Location Affects Outcomes in Paediatric Crohn's7/2/2025 10:38 AM European Behçet's Recommendations Forthcoming6/14/2025 12:14 PM Precision-Medicine Approach Improves IBD Infliximab Outcomes5/12/2025 12:37 AM Beyond Anti-TNF: Is Ustekinumab a Better Choice in Crohn's?3/28/2025 6:08 AM Vedolizumab Beats Infliximab as Second-Line Therapy for Ulcerative Colitis3/6/2025 3:06 AM New Biomarkers Identified for Treatment Response in IBD2/23/2025 9:46 PM
